MarketScreener Homepage > Equities > Swiss Exchange > Roche Holding AG ROG CH0012032048

Report

Delayed Swiss Exchange - 01/20 05:17:01 am
318.35	CHF		+0.05%

02:26a

ROCHE HOLDINGS AG : Jefferies maintains a Buy rating

01/19

CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise 2030 Renewable Energy Target

01/18

ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the independent proxy

Summary

Quotes 5-day view Delayed Quote.

Delayed Swiss Exchange

01/14/2021	01/15/2021	01/18/2021	01/19/2021	01/20/2021	Date
312.05(c)	316.65(c)	314.95(c)	318.2(c)	318.35	Last
1 848 324	2 350 861	1 434 363	1 225 765	248 222	Volume
+0.02%	+1.47%	-0.54%	+1.03%	+0.05%	Change

More quotes

Financials

Sales 2020	59 737 M 67 188 M 67 188 M
Net income 2020	14 387 M 16 181 M 16 181 M
Net cash position 2020	3 176 M 3 572 M 3 572 M
P/E ratio 2020	19,5x
Yield 2020	2,92%

Sales 2021	61 728 M 69 427 M 69 427 M
Net income 2021	15 176 M 17 069 M 17 069 M
Net cash position 2021	10 902 M 12 262 M 12 262 M
P/E ratio 2021	18,3x
Yield 2021	3,02%

Capitalization	273 B 307 B 307 B
EV / Sales 2020	4,52x
EV / Sales 2021	4,25x
Nbr of Employees	97 735
Free-Float	83,6%

More Financials

Company

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The...

Sector

Pharmaceuticals

Calendar

01/28

Presentation

More about the company

Notations Surperformance© of Roche Holding AG

Trading Rating :

Investor Rating :

More Ratings

All news about ROCHE HOLDING AG

02:26a	ROCHE HOLDINGS AG : Jefferies maintains a Buy rating	MD
01/19	CHUGAI PHARMACEUTICAL : Supports the Japan Climate Initiative's Calling to Raise..	AQ
01/18	ROCHE ANNUAL GENERAL MEETING 2021 : Exercising of shareholder rights via the ind..	AQ
01/18	PRESS RELEASE : Roche Annual General Meeting 2021: Exercising of shareholder rig..	DJ
01/15	ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating	MD
01/14	Qiagen warns against using standard tests to track coronavirus variants	RE
01/13	CHUGAI PHARMACEUTICAL : Conducts Digital Transformation in Manufacturing with IB..	AQ
01/13	ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..	MT
01/13	ROCHE HOLDINGS AG : JP Morgan reiterates its Neutral rating	MD
01/12	ROCHE : Unit Regeneron to Supply Additional Doses of COVID-19 Antibody Cocktail ..	MT
01/12	ROCHE : confirms US government agreement to purchase additional doses of Regener..	AQ
01/12	PRESS RELEASE : Roche confirms US government -2-	DJ
01/12	PRESS RELEASE : Roche confirms US government agreement to purchase additional do..	DJ
01/12	ROCHE : CHEPLAPHARM acquires the rights to Rivotril	AQ
01/12	ROCHE HOLDINGS AG : Receives a Buy rating from UBS	MD

More news

News in other languages on ROCHE HOLDING AG

02:26a	ROCHE HOLDINGS AG : Jefferies favorable sur le dossier
01/19	Aktien Schweiz verteidigen Anfangsgewinne nicht
01/18	ROCHE : prochaine AG sans présence physique des actionnaires
01/18	Roche-Generalversammlung findet ohne physische Anwesenheit der Aktionäre stat..
01/18	GLOBENEWSWIRE/ORDENTLICHE ROCHE GENE : Abstimmungen und Wahlen durch die unabhän..

More news

Analyst Recommendations on ROCHE HOLDING AG

02:26a	ROCHE HOLDINGS AG : Jefferies maintains a Buy rating	MD
01/15	ROCHE HOLDINGS AG : Deutsche Bank gives a Neutral rating	MD
01/13	ROCHE : Exane BNP Paribas Lowers Price Target on Roche, Maintains Outperform Rec..	MT

More recommendations

Stock Trading Strategies

	ROCHE HOLDING AG - 2020
Close to an important medium term support level

BUY

More Stock Trading Analysis

Provided by Scoopnest.com

Analysis

AstraZeneca shares fall on 'hefty' $39-billion Alexion deal